MedTrace Logo

Study in Patients With Mild to Moderate Psoriasis

NCT01451346 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 47

Last updated 2011-10-13

No results posted yet for this study

Summary

This was a randomized, double blind,fixed dose, placebo controlled, parallel-group pilot study to obtain data on size and variance of treatment effects in subjects with mild to moderate Psoriasis.

Conditions

Interventions

DIETARY_SUPPLEMENT

B. Infantis 35624

One sachet daily for 12 weeks

Sponsors & Collaborators

  • Whately-Smith Ltd, King's Langley,UK

    collaborator UNKNOWN

  • Alimentary Health Ltd

    lead INDUSTRY

Principal Investigators

  • Liam O Mahony, Dr. · Alimentary Health Ltd

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-01-31
Primary Completion
2008-04-30
Completion
2011-08-31

Countries

  • Ireland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01451346 on ClinicalTrials.gov